Galavit, 25 mg 20 pcs.

Immunomodulatory and anti-inflammatory agent.

CodeATH: L03 Pharmacological properties:

Pharmacodynamics

The mechanism of action of the drug is associated with its ability to regulate the functional and metabolic activity of cells of innate and adaptive immunity (monocytes, macrophages, neutrophils, natural killers, etc.).

Galavit normalizes phagocytic activity of monocytes/macrophages, bactericidal activity of neutrophils and cytotoxic activity of NK-cells. At the same time by restoring the reduced activity of cells of innate and adaptive immunity the preparation increases resistance of the organism to infectious diseases of bacterial, viral and fungal etiology, promotes faster elimination of the pathogen from the organism, reduces the frequency, severity and duration of infections.

Galavit decreases production of reactive oxygen species by hyperactivated macrophages thus reducing oxidative stress and protecting tissues and organs from damaging effects of radicals. Normalization of excessively elevated functional activity of phagocytic cells leads to restoration of their antigen-presenting and regulatory functions and reduction of autoaggression level.

The drug is well tolerated and has no allergizing, mutagenic, embryotoxic, teratogenic and carcinogenic action.

Pharmacokinetics

Extracted from the body mainly through the kidneys. With sublingual administration the elimination half-life is 30 minutes. The main pharmacological effects are observed within 72 hours.

Indications

Tonsillitis, Periodontitis, Otitis, Diarrhea, Urinary tract infections, Bronchitis, Inflammation in the mouth, Gastric and duodenal ulcers, Herpes, Colds, Sore throat, Alcoholism, Hepatitis, Boils

In adults and adolescents over 12 years (including those with secondary immune deficiency) as immunomodulatory and anti-inflammatory agent in the complex therapy:

• acute respiratory infections, diseases of the respiratory tract and ENT organs (including frequently relapsing) of bacterial and viral etiology (SARS, influenza, bronchitis, pneumonia, tonsillitis, otitis, adenoiditis) and their prevention;
• inflammatory diseases of the oral cavity and throat, periodontal disease
• chronic recurrent disease caused by herpes virus
• decrease physical performance (including in athletes).

.

Active ingredient

Sodium aminodihydrophthalazindione

Composition

1 tablet contains:

The active ingredients:

aminodihydrophthalazindione sodium – 25 mg

Associates:

sorbitol – 0.315 g,

starch – 0.14 g,

lactose – 0.1 g,

calcium stearate – 0.005 g,

talc – 0.015 g,

racenthol (menthol) – 0.0001 g.